Skip to Content

Notice

Foreign-Trade Zone (FTZ) 193-Clearwater, Florida; Authorization of Production Activity; Catalent Pharma Solutions, LLC (Pharmaceutical Products); St. Petersburg, Florida

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

On January 30, 2019, Catalent Pharma Solutions, LLC submitted a notification of proposed production activity to the FTZ Board for its facility within Subzone 193A, in St. Petersburg, Florida.

The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including notice in the Federal Register inviting public comment (84 FR 2812, February 8, 2019). On May 30, 2019, the applicant was notified of the FTZ Board's decision that no further review of the activity is warranted at this time. The production activity described in the notification was authorized, subject to the FTZ Act and the FTZ Board's regulations, including Section 400.14.

Start Signature

Dated: May 30, 2019.

Andrew McGilvray,

Executive Secretary.

End Signature End Preamble

[FR Doc. 2019-11719 Filed 6-4-19; 8:45 am]

BILLING CODE 3510-DS-P